# Compass Therapeutics, Inc.: Form 8-K, filed May 8, 2025

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K
- Filed: 2025-05-08
- Accepted by EDGAR: May 8, 2025, 12:00 ET
- Period: 2025-05-08
- Accession: 0001171843-25-002952
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000117184325002952/f8k_050725.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000117184325002952/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000117184325002952/f8k_050725.htm

Filed May 8, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-002952. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.